Tuesday, May 28, 2024
ADVT 
Health

Many steps needed for accurate COVID-19 test results

Darpan News Desk The Canadian Press, 18 Aug, 2020 10:09 PM
  • Many steps needed for accurate COVID-19 test results

A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don't follow the the latest updates from the manufacturer.

The Food and Drug Administration's warning over Thermo Fisher's TaqPath test underscores the complexity of COVID-19 tests and how easily they can be skewed by faulty processing and equipment.

The FDA action follows a report last month by Connecticut public health officials that the test resulted in at least 90 people receiving false positive results for the coronavirus.

WHAT HAPPENED WITH THE TEST?

Thermo Fisher’s test is one of the standard tools used to screen for COVID-19, run on large, automated machines found in many U.S. hospitals and laboratories. The FDA flagged two separate issues that could potentially result in false results: the chemical mixing process and computer software that runs on the company's machine. Thermo Fisher has provided new instructions for mixing. And a software update fixes the second problem, the FDA said.

For all positive results, FDA said labs should review the instrument settings.

Thermo Fisher said in a statement that its data shows the issues are rare and most users get accurate results by following company directions.

HOW ACCURATE ARE COVID-19 TESTS?

No test is 100% accurate and all medical tests are expected to deliver a certain small portion of false results. Less is known about the accuracy of COVID-19 tests because of how quickly they were rushed through the regulatory process because of the pandemic.

Thermo Fisher's test uses molecular technology that is considered the gold standard for detecting the COVID-19 virus and other viruses. The tests uses chemicals to extract the genetic material of the virus from a nasal swab, then amplifies it many times until it is detectable with a computer.

Thermo Fisher's test was among the first granted emergency use by the FDA in mid-March. Like other companies, it got the OK based on laboratory experiments it submitted to regulators. The test successfully detected coronavirus in 60 lab-made samples of the virus, and successfully ruled out the virus in 60 samples that didn't contain the virus. That was sufficient to meet FDA requirements..

However, experts have warned that these laboratory measures are very different from the large patient studies that assess the real-world performance of a test. Those studies can reveal factors that can skew results, such as faulty samples or incorrect processing .

HOW SIGNIFICANT ARE FALSE RESULTS?

The biggest concern during infectious disease outbreaks is usually avoiding false negatives, or when the test fails to catch people who are actually infected. That can result in some people unknowingly spreading the virus.

But Dr. Albert Ko of Yale’s School of Public Health noted that false positives can also create problems, particularly in places like nursing homes and prisons where people are grouped together based on test results.

“You may wind up putting someone who hasn’t been infected together with people who may be infected and are contagious,” Ko said.

Test results can be affected by a variety of factors, including the type of test used, the quality of the sample and when it was taken during the course of any infection.

MORE Health ARTICLES

Medicare coverage for Alzheimer brain scans in question

Medicare coverage for Alzheimer brain scans in question
A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing health care costs, calling into question whether the pricey tests are worth it.

Medicare coverage for Alzheimer brain scans in question

Rural Canada needs more anesthesia care: doctors

Rural Canada needs more anesthesia care: doctors
Canadians living in rural or remote communities are at risk of poorer health outcomes due to a shortage of anesthesia services, say researchers calling for a national strategy to address inequitable access to care.

Rural Canada needs more anesthesia care: doctors

CFIA investigates unsolicited seed shipments

CFIA investigates unsolicited seed shipments
The Canadian Food Inspection Agency is warning gardeners not to plant "unauthorized seeds" from packages they weren't expecting.

CFIA investigates unsolicited seed shipments

Scientists get closer to blood test for Alzheimer's disease

Scientists get closer to blood test for Alzheimer's disease
An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia.

Scientists get closer to blood test for Alzheimer's disease

COVID-19 recovery can take a few weeks even for young adults

COVID-19 recovery can take a few weeks even for young adults
Recovering from even mild coronavirus infections can take at least two to three weeks, according to U.S. research published Friday.

COVID-19 recovery can take a few weeks even for young adults

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support
DO WATCH & PLEASE SHARE AS MUCH AS POSSIBLE! Baby Aryan's parents urge the community to help as the baby was diagnosed with TYPE 1 SPINAL MUSCULAR ATROPHY (SMA). There is a treatment available called ZOLGENSMA which is the most expensive drug in the world at this time it costs 2.1 million dollars USD (2.8 Million CAD).

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support